Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy (Q34029815)

30 July 2017

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy (English)

1 reference

30 July 2017

0 references

1 reference

Tim Friede

25

1 reference

ORCID Public Data File 2021

Patrick Niaudet

20

object named as

Patrick Niaudet

1 reference

30 July 2017

17

Bertrand Knebelmann

1 reference

30 July 2017

19

Jean-Pierre Grunfeld

1 reference

30 July 2017

Oliver Gross

1

1 reference

30 July 2017

Christoph Licht

2

1 reference

30 July 2017

Hans J Anders

3

1 reference

30 July 2017

Bernd Hoppe

4

1 reference

30 July 2017

Bodo Beck

5

1 reference

30 July 2017

Burkhard Tönshoff

6

1 reference

30 July 2017

Britta Höcker

7

1 reference

30 July 2017

Simone Wygoda

8

1 reference

30 July 2017

Jochen H H Ehrich

9

1 reference

30 July 2017

Lars Pape

10

1 reference

30 July 2017

Martin Konrad

11

1 reference

30 July 2017

Wolfgang Rascher

12

1 reference

30 July 2017

Jörg Dötsch

13

1 reference

30 July 2017

Dirk E Müller-Wiefel

14

1 reference

30 July 2017

Peter Hoyer

15

1 reference

30 July 2017

Study Group Members of the Gesellschaft für Pädiatrische Nephrologie

16

1 reference

30 July 2017

Yves Pirson

18

1 reference

30 July 2017

Pierre Cochat

21

1 reference

30 July 2017

Laurence Heidet

22

1 reference

30 July 2017

Said Lebbah

23

1 reference

30 July 2017

Roser Torra

24

1 reference

30 July 2017

Katharina Lange

26

1 reference

30 July 2017

Gerhard A Müller

27

1 reference

30 July 2017

Manfred Weber

28

1 reference

30 July 2017

language of work or name

English

0 references

publication date

14 December 2011

1 reference

30 July 2017

1 reference

30 July 2017

81

1 reference

30 July 2017

5

1 reference

30 July 2017

494-501

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2011.407

30 July 2017

0 references

cites work

Chronic kidney disease predicts cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

World Kidney Day: hypertension and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Renoprotection: clues from knockout models of rare diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Treatment of Alport syndrome: beyond animal models

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Genetics of classic Alport's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Enalapril in children with Alport syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Strict blood-pressure control and progression of renal failure in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Blood-pressure control and delay in progression of kidney disease in children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Proteinuria: Is the ONTARGET renal substudy actually off target?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

The RAAS in the pathogenesis and treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

World Kidney Day 2009: problems and challenges in the emerging epidemic of kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

Genotype-phenotype correlation in X-linked Alport syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.407

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2011.407

1 reference

7 January 2021

Identifiers

DOI

10.1038/KI.2011.407

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference